|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
15
|
|
pubmed:dateCreated |
2001-10-9
|
|
pubmed:abstractText |
Estrogen increases endothelium-dependent vasodilation in postmenopausal women. However, use of progestins in combination with estrogen may counter beneficial effects of estrogen on endothelium. We investigated the effect of medroxyprogesterone acetate (MPA) on estrogen-induced increase in endothelium-dependent vasodilation in postmenopausal women.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Estradiol,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogens, Conjugated (USP),
http://linkedlifedata.com/resource/pubmed/chemical/Estrone,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Medroxyprogesterone Acetate,
http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
9
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1773-8
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:11591613-Blood Flow Velocity,
pubmed-meshheading:11591613-Blood Pressure,
pubmed-meshheading:11591613-Brachial Artery,
pubmed-meshheading:11591613-Cholesterol,
pubmed-meshheading:11591613-Cholesterol, HDL,
pubmed-meshheading:11591613-Cholesterol, LDL,
pubmed-meshheading:11591613-Dose-Response Relationship, Drug,
pubmed-meshheading:11591613-Drug Antagonism,
pubmed-meshheading:11591613-Endothelium, Vascular,
pubmed-meshheading:11591613-Estradiol,
pubmed-meshheading:11591613-Estrogens, Conjugated (USP),
pubmed-meshheading:11591613-Estrone,
pubmed-meshheading:11591613-Female,
pubmed-meshheading:11591613-Heart Rate,
pubmed-meshheading:11591613-Humans,
pubmed-meshheading:11591613-Japan,
pubmed-meshheading:11591613-Lipoproteins, LDL,
pubmed-meshheading:11591613-Medroxyprogesterone Acetate,
pubmed-meshheading:11591613-Middle Aged,
pubmed-meshheading:11591613-Oxidation-Reduction,
pubmed-meshheading:11591613-Postmenopause,
pubmed-meshheading:11591613-Vascular Patency,
pubmed-meshheading:11591613-Vasodilation,
pubmed-meshheading:11591613-Vasodilator Agents
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Kochi Medical School, Kochi, Japan. wakatuki@kochi-ms.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
